You are here

Roche

Regeneron and Roche's antibody cocktail shown helping in COVID-19 cases

Reuters

Tue, 03/23/21 - 10:42 am

clincial trials

Roche cuts bait on late-stage study of Huntington's med tominersen, an Ionis import with prior safety flags

Endpoints

Mon, 03/22/21 - 09:56 pm

Huntington's disease

Roche's Tecentriq is the first I-O drug to claim a post-surgery win in lung cancer. But will doctors use it?

Fierce Pharma

Mon, 03/22/21 - 10:48 am

non-small cell lung cancer

Horizon, Roche's Genentech, AbbVie and Neurocrine rank as top pharma places to work in annual poll

Fierce Pharma

Thu, 03/18/21 - 11:01 am

Horizon Therapeutics

employee satisfaction

Potential False Results with Roche Molecular Systems’ SARS-CoV-2 Assay

FDA Law Blog

Thu, 03/18/21 - 10:47 am

Roche Molecular Systems

Roche launches test to monitor emerging coronavirus variants

Pharmaforum

Tue, 03/16/21 - 11:00 am

COVID-19 variants

Roche drops $1.85B for GenMark's testing tech as pandemic, antibiotic resistance threats loom

Endpoints

Mon, 03/15/21 - 10:50 am

GenMark Diagnostics

GSK, Novo and Roche meds hit pandemic potholes while Dupixent, Humira stood strong: analysts

Fierce Pharma

Sat, 03/13/21 - 10:19 pm

In the latest twist to IL-6 roller coaster, Roche's Actemra fails PhIII Covid-19 Veklury combo trial

Endpoints

Thu, 03/11/21 - 10:34 am

clinical trials

COVID-19 pneumonia

Industry-wide accelerated approval review yields four withdrawals

RAPS.org

Wed, 03/10/21 - 10:53 pm

Bristol-Meyers Squibb

accelerated approvals

Roche joins the FDA accelerated approval revamp team, nixing a Tecentriq bladder cancer nod

Fierce Pharma

Mon, 03/8/21 - 11:12 am

FDA Approves First Biologic for Rare, Debilitating Lung Disease

BioSpace

Sun, 03/7/21 - 01:35 pm

Roche is gearing up to knock down an Irish plant—and it's complicated

Fierce Pharma

Thu, 03/4/21 - 11:28 pm

drug manufacturing

Pfizer's Lorbrena breaks into front-line ALK lung cancer, jostling with Novartis, Roche and Takeda

Fierce Pharma

Thu, 03/4/21 - 11:21 pm

non-small cell lung cancer

A busy year ahead for Parkinson’s disease

EP Vantage

Wed, 03/3/21 - 10:56 am

Parkinson's Disease

drug development

SAGE Therapeutics

Merck inks $1.9B Pandion takeover to square up against Amgen, Lilly and Roche

Fierce Biotech

Thu, 02/25/21 - 10:44 am

immune modulators

Medtech’s haves and have-nots

EP Vantage

Wed, 02/24/21 - 10:59 am

Boston Scientific

The big Covid-19 trials still to report

EP Vantage

Wed, 02/17/21 - 10:48 am

clinical trials

Genentech Could Regain the Blindness-Related Disease Market with New Treatment

BioSpace

Sat, 02/13/21 - 11:01 pm

clinical trials

age-related macular degeneration

Versant spinout lands $80M to go 'much broader' than the old Roche partnership that birthed it

Endpoints

Thu, 02/11/21 - 10:38 pm

Versant Ventures

Pipeline Therapeutics

Pages